Alzheimer's disease and other dementing conditions
- PMID: 18941718
- DOI: 10.1007/s10072-008-1003-5
Alzheimer's disease and other dementing conditions
Abstract
Dementia is a common and growing problem, with 20% of those over 80 years of age suffering from this disorder. The prospect of more effective treatments has caused an increasing demand for a more accurate and earlier diagnosis of different dementia syndromes. Neuroimaging techniques may have an important role in the clinical evaluation of dementia for early diagnosis, differential diagnosis and may help in the prediction of conversion to dementia in individuals at a higher risk of developing the disorder. Moreover, new MRI techniques might not only further broaden our understanding of the pathophysiology but also accelerate treatment discovery. This review will focus on the use of conventional and non-conventional MRI techniques to investigate dementias.
Similar articles
-
Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1685-96. doi: 10.1007/s00259-002-0967-2. Epub 2002 Sep 25. Eur J Nucl Med Mol Imaging. 2002. PMID: 12458405 Review.
-
[Brain imaging--a support in the investigation of dementia].Lakartidningen. 2009 May 13-19;106(20):1390-5. Lakartidningen. 2009. PMID: 19585837 Swedish. No abstract available.
-
Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.Hong Kong Med J. 2016 Aug;22(4):327-33. doi: 10.12809/hkmj154707. Epub 2016 Jun 17. Hong Kong Med J. 2016. PMID: 27313272
-
Methodological problems and clinical relevance of structural neuroimaging in dementia research.J Neural Transm Gen Sect. 1995;99(1-3):131-43. doi: 10.1007/BF01271474. J Neural Transm Gen Sect. 1995. PMID: 8579800 Review.
-
[New perspectives on Alzheimer's disease from neuroimaging].Rev Neurol. 2010 Mar 16;50 Suppl 5(Suppl 5):S23-6. Rev Neurol. 2010. PMID: 20517866 Free PMC article. Spanish.
Cited by
-
Epidemiology and Risk Factors of Alzheimer's Disease in Iran: A Systematic Review.Iran J Public Health. 2019 Dec;48(12):2133-2139. Iran J Public Health. 2019. PMID: 31993381 Free PMC article. Review.
-
Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.Mol Neurobiol. 2013 Dec;48(3):412-28. doi: 10.1007/s12035-013-8428-4. Epub 2013 Feb 19. Mol Neurobiol. 2013. PMID: 23420079 Review.
-
Perception of Alzheimer Disease in Iranian Traditional Medicine.Iran Red Crescent Med J. 2016 Mar 1;18(3):e22054. doi: 10.5812/ircmj.22054. eCollection 2016 Mar. Iran Red Crescent Med J. 2016. PMID: 27247784 Free PMC article. Review.
-
A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.Psychopharmacology (Berl). 2010 Jan;207(4):637-43. doi: 10.1007/s00213-009-1706-1. Epub 2009 Oct 20. Psychopharmacology (Berl). 2010. PMID: 19838862 Clinical Trial.
-
Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer's disease.Neurol Sci. 2013 Aug;34(8):1447-51. doi: 10.1007/s10072-012-1263-y. Epub 2012 Dec 11. Neurol Sci. 2013. PMID: 23229411
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical